Arcutis Biotherapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $99,219 | $81,504 | $65,846 | $71,360 |
Gross Profit | 90,534 | 74,012 | 57,016 | 64,455 |
EBITDA | 11,123 | -11,952 | -18,667 | -4,456 |
EBIT | 10,561 | -12,515 | -21,799 | -4,914 |
Net Income | 7,410 | -15,886 | -25,060 | -10,788 |
Net Change In Cash | 99,219 | 81,504 | 65,846 | 71,360 |
Free Cash Flow | -1,754 | 246 | -30,988 | -5,748 |
Cash | 47,120 | 73,048 | 53,104 | 71,335 |
Basic Shares | 132,885 | 126,997 | 126,037 | 120,958 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $196,542 | $59,606 | $3,686 | $0 |
Gross Profit | 177,414 | 54,619 | 2,932 | -763 |
EBITDA | -109,625 | -227,434 | -294,553 | -206,075 |
EBIT | -112,224 | -229,315 | -295,806 | -206,529 |
Net Income | -140,039 | -262,140 | -311,458 | -205,902 |
Net Change In Cash | 196,542 | 59,606 | 3,686 | 0 |
Cost of Revenue | 31,367 | |||
Free Cash Flow | -112,301 | -247,485 | -280,998 | -175,622 |
Cash | 71,335 | 88,398 | 53,641 | 97,991 |
Basic Shares | 120,958 | 69,305 | 55,032 | 49,406 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0.06 |
2025-06-30 | -$0.13 |
2025-03-31 | -$0.20 |
2024-12-31 | -$0.09 |
